Monoclonal antibodies specific for oxidized calcium/calmodulin dependent protein kinase II
US8841423B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Apr 27, 2009 |
| Grant date | Sep 23, 2014 |
| Priority date | — |
| Expiry date | Mar 17, 2031 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/32
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Calcium/calmodulin dependent protein kinase II (CaMKII) has been found to be directly oxidized, and direct oxidation of CaMKII was observed to result in calcium independent activation of CaMKII. Antibodies that bind specifically to oxidized forms of CaMKII (oxCaMKII) were generated and were utilized to detect oxCaMKII in blood from: (1) mice with cancer; (2) mice with a knock out of the gene encoding methionine sulfoxide reductase; (3) mice injected with angiotensin II; (4) mice injected with bacterial endotoxin; (5) mice fed a pro-oxidant (ketogenic) diet; and (6) mice with cancer that had been treated with experimental therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.